Paul Tudor Jones’s Roivant Sciences ROIV Stock Holding History

Paul Tudor Jones’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$648K	Buy	18,300 +8,900	+95%	+$263K	﹤0.01%	2687
2026 Q1	$260K	Sell	9,400 -25,400	-73%	-$653K	﹤0.01%	3225
2025 Q4	$755K	Buy	+34,800	New	+$687K	﹤0.01%	2470

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Paul Tudor Jones's ROIV Position: Q3 2025 in Review

Paul Tudor Jones sold out of Roivant Sciences (ROIV) in Q3 2025, closing a stake of 76,262 shares — an estimated $944K sold.

Paul Tudor Jones first reported a position in ROIV in Q2 2022 and held it in 10 quarters. The position peaked at $3.33M in Q2 2023. 338 funds tracked by Wall St. Rank hold ROIV as of Q3 2025.

Paul Tudor Jones reported no remaining Roivant Sciences position as of Q3 2025 after selling out during the quarter.
Paul Tudor Jones sold 76,262 Roivant Sciences shares in Q3 2025, an estimated $944K.
Paul Tudor Jones first reported a position in Roivant Sciences in Q2 2022 and held it in 10 quarters.
Paul Tudor Jones's Roivant Sciences position peaked at $3.33M in Q2 2023.
338 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2025.

Based on Tudor Investment Corp's 13F filing for Q3 2025, filed 14 Nov 2025.